United States Biotechnology & Medical Research

Gain Therapeutics Inc (GANX)

Track

Track

Gain Therapeutics Inc has recorded no insider trading activity within the past three months. The most recent transactions occurred on August 9, 2024, when the CFO and Executive Chairman purchased shares. Prior historical filings show various acquisition and disposal patterns by company leadership, with the latest recorded movement dating back over ninety days.
Ticker: GANX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Gain Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Mack Gene CFO and Interim CEO Officer
Transaction date
Purchase
Price
66.73
Quantity 15,602 -15.9%
Value US$3,322,826
3.3
Islam Khalid Executive Chairman Executive Director
Transaction date
Purchase
Price
126.02
Quantity 71,610 +25.3%
Value US$3,497,910
3.8
RICHMAN ERIC I Non-Executive Director
Transaction date
Purchase
Price
162.61
Quantity 67,802 +22.7%
Value US$1,229,142
3.8
RICHMAN ERIC I Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 5,000 +1.8%
Value US$6,150
0.5
Riley Jeffrey Scott Non-Executive Director
Transaction date
Purchase
Price
3.86
Quantity 30,000 +inf%
Value US$115,770
0.9
Alder Matthias Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.46
Quantity 206 -3.8%
Value US$507
0.9
Alder Matthias Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.50
Quantity 1,820 -27.3%
Value US$4,550
3.8
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.58
Quantity 2,482 +1.2%
Value US$6,404
3.8
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.83
Quantity 9,256 +4.5%
Value US$26,194
3.8
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.71
Quantity 4,000 +2.0%
Value US$10,840
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-12 2024-08-09 B Purchase
3.3
Mack Gene

CFO and Interim CEO

Officer
15,602 -15.9%
66.73
US$3,322,826 		15,602 -15.9% 66.73 US$3,322,826
2024-08-12 2024-08-09 B Purchase
3.3
Islam Khalid

Executive Chairman

Executive Director
71,610 +25.3%
126.02
US$3,497,910 		71,610 +25.3% 126.02 US$3,497,910
2024-07-01 2024-07-01 B Purchase
3.8
RICHMAN ERIC I
Non-Executive Director
67,802 +22.7%
162.61
US$1,229,142 		67,802 +22.7% 162.61 US$1,229,142
2024-07-01 2024-07-01 B Purchase
3.8
RICHMAN ERIC I
Non-Executive Director
5,000 +1.8%
1.23
US$6,150 		5,000 +1.8% 1.23 US$6,150
2024-04-01 2024-03-28 B Purchase
0.5
Riley Jeffrey Scott
Non-Executive Director
30,000 +inf%
3.86
US$115,770 		30,000 +inf% 3.86 US$115,770
2023-12-22 2023-12-21 S Sale
0.9
Alder Matthias

Chief Executive Officer

Executive Director
206 -3.8%
2.46
US$507 		206 -3.8% 2.46 US$507
2023-12-14 2023-12-07 S Sale
0.9
Alder Matthias

Chief Executive Officer

Executive Director
1,820 -27.3%
2.50
US$4,550 		1,820 -27.3% 2.50 US$4,550
2022-05-27 2022-05-25 B Purchase
3.8
RICHMAN ERIC I

CHIEF EXECUTIVE OFFICER

Executive Director
2,482 +1.2%
2.58
US$6,404 		2,482 +1.2% 2.58 US$6,404
2022-05-23 2022-05-20 B Purchase
3.8
RICHMAN ERIC I

CHIEF EXECUTIVE OFFICER

Executive Director
9,256 +4.5%
2.83
US$26,194 		9,256 +4.5% 2.83 US$26,194
2022-05-23 2022-05-19 B Purchase
3.8
RICHMAN ERIC I

CHIEF EXECUTIVE OFFICER

Executive Director
4,000 +2.0%
2.71
US$10,840 		4,000 +2.0% 2.71 US$10,840
Explore more

More insider trading research around Gain Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America